Avidity Biosciences Inc (RNA)
50.00
-2.55
(-4.85%)
USD |
NASDAQ |
Nov 14, 16:00
49.98
-0.02
(-0.04%)
After-Hours: 16:47
Avidity Biosciences Total Assets (Quarterly): 1.347B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.347B |
| March 31, 2024 | 951.47M |
| December 31, 2023 | 628.56M |
| September 30, 2023 | 573.16M |
| June 30, 2023 | 610.78M |
| March 31, 2023 | 613.98M |
| December 31, 2022 | 638.80M |
| September 30, 2022 | 430.54M |
| June 30, 2022 | 420.80M |
| March 31, 2022 | 421.14M |
| Date | Value |
|---|---|
| December 31, 2021 | 427.58M |
| September 30, 2021 | 425.92M |
| June 30, 2021 | 290.52M |
| March 31, 2021 | 314.75M |
| December 31, 2020 | 333.90M |
| September 30, 2020 | 346.13M |
| June 30, 2020 | 355.36M |
| March 31, 2020 | 92.68M |
| December 31, 2019 | 96.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
92.68M
Minimum
Mar 2020
1.347B
Maximum
Jun 2024
490.55M
Average
425.92M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 3.600B |
| Natera Inc | 1.517B |
| Entrada Therapeutics Inc | 554.59M |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Catalyst Pharmaceuticals Inc | 772.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 126.39M |
| Shareholders Equity (Quarterly) | 1.221B |
| Current Ratio | 15.78 |